Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Dapt-Rivaroxaban'
Dapt-Rivaroxaban published presentations and documents on DocSlides.
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
A ssessment of D ual antiplatelet therapy versus
by stefany-barnette
A ssessment of D ual antiplatelet therapy versus...
Dual Antiplatelet Therapy (DAPT) Duration
by tatiana-dople
Dilemma: Recent Trials And Guidelines For. Clinic...
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
by giovanna-bartolotta
Rivaroxaban Plus Aspirin in Patients With and Wit...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
Aspirin in 2022: A New Aspirin for a New Chapter
by belinda
March 28, 2022. Disclosures. Present Research/Gran...
Dominick J. Angiolillo
by SunnySeahorse
, MD. , PhD. Professor. of Medicine. Medical Dire...
DUAL ANTIPLATELET THERAPY
by mary
(DAPT) . BHAVI SHAH, DNP, APRN, ANP-C. UNIVERSITY ...
Evidence-Based Antiplatelet Therapy Across the ACS Spectrum
by debby-jeon
Evidence-Based Antiplatelet Therapy Across the AC...
What Has Been Tried and What Is True?
by celsa-spraggs
What Has Changed?. Less Stent Thrombosis . With. ...
Sangramento GI associado a PCI
by marina-yarberry
Juan Felipe Castillo Schrul. Residente Hemodinâm...
School Life in Australia
by trish-goza
Presented By Kiahna Bailey and Paige Herford. Sch...
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
Ima A. Kusuma , MD, FIHA
by hirook
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Recent ACS: STEMI, NSTEMI, UA
by danika-pritchard
Stabilized 1-7 Days Post-Index Event. Exclusions:...
Dual Anti-Platelet Therapy After TAVR?
by salem
By: Cole Smith PharmD Candidate 2021. University o...
One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes:
by yvonne
Principal Results From the Double-blind, Placebo-c...
SFA Intervention: In for a Penny
by hadley
Michael N. Young, MD, RPVI. Dartmouth-Hitchcock He...
MOACTFCAI DAPTOLBKTBOLILDVCBBORAOV 24
by harper
20 INTRODUCTION M a glycerol molecule attached to ...
MOACTICAI DAPTOLBNTBOLILDYLCTLBBO 21
by ariel
30 Patrick Berg Richard W. McCallum Mark Hall Iren...
Department of Clinical Effectiveness
by roxanne
V 3 Approved by Executive Committee of the Medical...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
Load More...
